Govt to decriminalise 1,000 minor offences, overhaul IP regime

New Delhi:  The Government will identify 1,000 provisions penalising minor offences within the next 45 days for decriminalisation, commerce and industry minister Piyush Goyal said on Wednesday.

He also invited stakeholder inputs for a review of various laws governing intellectual property (IP) to simplify and make them more user-friendly. Based on the feedback, the government may amend existing laws or introduce new ones, as was done with the new Income Tax Bill.

The initiative aims to make India’s IP framework more innovation-friendly while ensuring affordability and access to medicines.

“We are focused on data exclusivity, but without evergreening creeping into our system,” Goyal told IP stakeholders, warning that patent evergreening could result in costly medicines and invite retaliatory taxes from other countries.

Goyal described data exclusivity as the “last missing link” before India could attract significant R&D inflows. He noted that two of the most dissatisfied stakeholders with India’s patent laws – Switzerland and the UK – have already completed an IP chapter with India in ongoing trade negotiations.

Related Posts

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

New Delhi: In a major crackdown on the sale of expired and substandard products, the Central Range team of Delhi Police Crime Branch has arrested one person and seized nearly…

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

Washington:  On March 18, 2026, the U.S. Food and Drug Administration (FDA) issued a draft guidance titled General Considerations for the Use of New Approach Methodologies in Drug Development. The…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

Delhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One Arrested

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

FDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug Development

IPC releases draft NFI-2026 to promote rational use of medicines

IPC releases draft NFI-2026 to promote rational use of medicines

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

Moonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic Surgery

US market to dent India pharma earnings even as domestic growth remains firm

US market to dent India pharma earnings even as domestic growth remains firm

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg

Biocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mg